SCHEMBL24915904

SCHEMBL24915904

CC(C)C(=O)NCC1CNC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.37
PREP P48147 1/20 0.37
FAP Q12884 1/20 0.37
ALOX15 P16050 2/20 0.35
MTNR1A P48039 3/20 0.35
MTNR1B P49286 3/20 0.35
TDP1 Q9NUW8 1/20 0.34
CHRNB2 P17787 3/20 0.34
CHRNB4 P30926 3/20 0.34
CHRNA3 P32297 3/20 0.34
CHRNA4 P43681 3/20 0.34
CHRNA7 P36544 2/20 0.34
KMT2A Q03164 2/20 0.34
BUB1 O43683 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
TSHR P16473 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ERCC1 P07992 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459955 0.87 SLC6A1 (0.46) DPP4PREPFAPALOX15SIGMAR1
SCHEMBL13459954 0.87 SLC6A1 (0.46) DPP4PREPFAPALOX15SIGMAR1
SCHEMBL12413661 0.87 SLC6A1 (0.46) DPP4PREPFAPALOX15SIGMAR1
SCHEMBL22752189 0.84 CPN1 (0.44) DPP4PREPFAPKMT2ASIGMAR1
SCHEMBL22752000 0.84 CPN1 (0.44) DPP4PREPFAPKMT2ASIGMAR1
SCHEMBL12413663 0.84 CPN1 (0.44) DPP4PREPFAPKMT2ASIGMAR1
SCHEMBL1107035 0.83 TDP1 (0.52) DPP4PREPFAPTDP1KMT2A
SCHEMBL10446115 0.82 ALOX15 (0.54) DPP4PREPFAPALOX15TDP1
SCHEMBL21661508 0.80 ALDH1A1 (0.46) DPP4PREPFAPMTNR1AMTNR1B
SCHEMBL12026402 0.79 EPHX1 (0.52) DPP4PREPFAPTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 DPP4 3355/4885PREP 3511/4885FAP 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.